Heregulin-expressing HER2-positive breast and gastric cancer exhibited heterogeneous susceptibility to the anti-HER2 agents lapatinib, trastuzumab and T-DM1
Nonagase, Yoshikane, Yonesaka, Kimio, Kawakami, Hisato, Watanabe, Satomi, Haratani, Koji, Takahama, Takayuki, Takegawa, Naoki, Ueda, Hiroto, Tanizaki, Junko, Hayashi, Hidetoshi, Yoshida, Takeshi, Takeda, Masayuki, Chiba, Yasutaka, Tamura, Takao, Nakagawa, Kazuhiko, Tsurutani, Junji
Published in Oncotarget (20.12.2016)
Published in Oncotarget (20.12.2016)
Get full text
Journal Article